Real-World Experience of Upadacitinib in Treatment of Adults With Moderate to Severe Ulcerative Colitis

被引：0
|
作者：
Chowla, Navreet M. [1 ]
Tariq, Raseen [1 ]
Aggarwal, Manik [1 ]
Loftus, Edward V. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1075
引用
收藏
页码：S820 / S820
页数：1
相关论文
共 50 条
  • [31] Upadacitinib is effective and safe for the treatment of ulcerative colitis and Crohn's disease: 1-year prospective real-world experience
    Cleveland, N. Krugliak
    Choi, N. K.
    Klein, J. A.
    Fear, E. N.
    Fine, Z. D.
    Garcia, N. M.
    Picker, E. A.
    Friedberg, S. R.
    Cohen, R. D.
    Dalal, S. R.
    Pekow, J.
    Choi, D.
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I928 - I929
  • [32] UPADACITINIB IS EFFECTIVE AND SAFE FOR THE TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE: 1-YEAR PROSPECTIVE REAL-WORLD EXPERIENCE
    Cleveland, Noa Krugliak
    Choi, Natalie K.
    Klein, Jeremy A.
    Fear, Evan N.
    Fine, Zachary D.
    Garcia, Nicole M.
    Picker, Emma A.
    Friedberg, Scott
    Cohen, Russell D.
    Dalal, Sushila R.
    Pekow, Joel
    Choi, David
    Rubin, David T.
    GASTROENTEROLOGY, 2024, 166 (05) : S1141 - S1142
  • [33] Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience
    Honap, Sailish
    Pavlidis, Polychronis
    Ray, Shuvra
    Sharma, Esha
    Anderson, Simon
    Sanderson, Jeremy D.
    Mawdsley, Joel
    Samaan, Mark A.
    Irving, Peter M.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (11) : E147 - E149
  • [34] Effectiveness of tofacitinib in a real-world Israeli cohort of patients with moderate-severe ulcerative colitis
    Biron, I. Avni
    Shitrit, A. Bar-Gil
    Koslowsky, B.
    Kopylov, U.
    Levartovsky, A.
    Weisshof, R.
    Aviv-Cohen, N.
    Maharshak, N.
    Hovel, D.
    Naftali, T.
    Goren, I.
    Snir, I.
    Ollech, J.
    Banai, H.
    Lena, B.
    Dotan, I.
    Yanai, H.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S498 - S499
  • [35] The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan
    Hagino, Teppei
    Saeki, Hidehisa
    Kanda, Naoko
    JOURNAL OF DERMATOLOGY, 2022, 49 (11): : 1158 - 1167
  • [36] REAL-WORLD EXPERIENCE WITH CURCUMIN-QINGDAI IN MANAGING ADULTS WITH ACTIVE ULCERATIVE COLITIS
    Peraza, Jellyana
    Salomon, Nir
    George, James
    INFLAMMATORY BOWEL DISEASES, 2025, 31 : S73 - S74
  • [37] Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
    Michael V. Chiorean
    Jessica R. Allegretti
    Puza P. Sharma
    Benjamin Chastek
    Leonardo Salese
    Elizabeth J. Bell
    Jesse Peterson-Brandt
    Joseph C. Cappelleri
    Xiang Guo
    Nabeel Khan
    BMC Gastroenterology, 22
  • [38] Comparative Effectiveness of Upadacitinib and Tofacitinib in Inducing Remission in Ulcerative Colitis: Real-World Data
    Boneschansker, Leo
    Ananthakrishnan, Ashwin N.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (09) : 2427 - +
  • [39] Real-world comparative safety of filgotinib and upadacitinib for ulcerative colitis: a propensity score matching
    Nogami, A.
    Asonuma, K.
    Okabayashi, S.
    Ikenouchi, M.
    Shinzaki, S.
    Fukata, M.
    Kobayashi, T.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2117 - i2118
  • [40] TOFACITINIB IN ULCERATIVE COLITIS: EARLY REAL-WORLD EXPERIENCE IN SOUTHAMPTON
    Young, David
    Ventress, Esther
    Harris, Richard
    McDonnell, Martin
    Bettey, Marion
    Gwiggner, Markus
    Felwick, Richard
    Smith, Trevor
    Cummings, Fraser
    GUT, 2021, 70 : A130 - A130
12345